Entrada Therapeutics (TRDA) Interest & Investment Income (2022 - 2025)
Historic Interest & Investment Income for Entrada Therapeutics (TRDA) over the last 4 years, with Q3 2025 value amounting to $3.6 million.
- Entrada Therapeutics' Interest & Investment Income fell 3806.8% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.1 million, marking a year-over-year decrease of 844.51%. This contributed to the annual value of $19.5 million for FY2024, which is 2796.69% up from last year.
- According to the latest figures from Q3 2025, Entrada Therapeutics' Interest & Investment Income is $3.6 million, which was down 3806.8% from $3.9 million recorded in Q2 2025.
- In the past 5 years, Entrada Therapeutics' Interest & Investment Income ranged from a high of $5.8 million in Q3 2024 and a low of $403000.0 during Q2 2022
- Moreover, its 4-year median value for Interest & Investment Income was $4.1 million (2023), whereas its average is $3.3 million.
- Per our database at Business Quant, Entrada Therapeutics' Interest & Investment Income surged by 94665.01% in 2023 and then tumbled by 3806.8% in 2025.
- Entrada Therapeutics' Interest & Investment Income (Quarter) stood at $950000.0 in 2022, then surged by 351.79% to $4.3 million in 2023, then increased by 19.48% to $5.1 million in 2024, then tumbled by 30.36% to $3.6 million in 2025.
- Its Interest & Investment Income stands at $3.6 million for Q3 2025, versus $3.9 million for Q2 2025 and $4.4 million for Q1 2025.